Description
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
AGDV is a C-terminal peptide sequence found on fibrinogen that is known as a binding site for glycoprotein IIb/IIIa (integrin αIIbβ3); this binding is required for platelet adhesion and aggregation.
| Purity | ≥95% |
|---|---|
| Formula | C14H24N4O7 |
| Formula Wt. | 360.37 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Srokowski EM, Woodhouse KA. Evaluation of the bulk platelet response and fibrinogen interaction to elastin-like polypeptide coatings. J Biomed Mater Res A. 2014 Feb;102(2):540-51. PMID: 23505204.
Podolnikova NP, Gorkun OV, Loreth RM, et al. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa). Biochemistry. 2005 Dec 27;44(51):16920-30. PMID: 16363805.
Liu Q, Rooney MM, Kasirer-Friede A, et al. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Biochim Biophys Acta. 1998 Jun 11;1385(1):33-42. PMID: 9630497.
Folic acid derivative
Platelet substitute, peptide; GP IIb/IIIa activ...
5-HT1A agonist, 5-HT2A antagonist.
Staurosporine analog; PKC inhibitor.
p110α inhibitor.
Alkaloid found in Corydalis and Stephania; D1/2...
Endogenous peptide, involved in paracrine and a...
5-HT2/3/6/7, D2/3/4, histamine H1, α1-adrenerg...
Aminoglycoside; protein translation inhibitor, ...
Fungistatic
Carcinoembryonic antigen epitope.
Endogenous peptide hormone inolved in gastric e...
Selective inhibitor of the γ isoform of PI3K (...
GPR84 agonist.
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Endogenous peptide, involved in paracrine and a...
DPP4 inhibitor.
Heterocyclic light-emitting compound, natural l...
Thienylbutyl ITC analog.
pan-Bcr-Abl tyrosine kinase inhibitor.